文献速递颈动脉与弓上血管

颈动脉内膜剥脱术与再次支架置入术在既往同侧颈动脉支架患者中的比较

Endarterectomy versus stenting in patients with prior ipsilateral carotid artery stenting.
PubMed 文献 · J Vasc Surg · 2017-02-09

本研究基于VQI数据库2003年至2016年645例既往同侧CAS后接受CEA(134例)或再次CAS(511例)的患者,比较30天和1年卒中、死亡、心梗等结局。作者建议避免对无症状严重系统性疾病患者行CEA,并强调糖尿病管理和戒烟。

要点

  • 既往同侧CAS后,CEA与再次CAS的30天卒中率和1年卒中/死亡风险无显著差异。
  • 建议避免对无症状且合并严重系统性疾病的患者行CEA,再次CAS患者应强化糖尿病管理和戒烟。

核心结论

  • 既往同侧CAS后行CEA或再次CAS,围手术期和1年结局无显著差异,但CEA组绝对死亡率更高,且CEA患者病情更重。

研究设计与样本

  • 基于VQI数据库的回顾性队列研究,纳入2003年1月1日至2016年4月30日期间既往同侧CAS后接受CEA(134例)或再次CAS(511例)的645例颈动脉干预。

临床怎么用

  • 对于既往同侧CAS后需再次干预的患者,CEA和再次CAS均可选择,但CEA应避免用于无症状且合并严重系统性疾病者。
  • 再次CAS患者应强化糖尿病管理和戒烟以改善结局。

局限性

  • 原文未报告

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In-stent restenosis is a recognized complication of carotid angioplasty and stenting (CAS), and it is associated with an increased risk of stroke. Few case series have reported outcomes separately following carotid endarterectomy (CEA) and CAS for the treatment of in-stent restenosis. In this study, we perform an evaluation of redo-CAS vs CEA in a large contemporary cohort of patients who underwent prior ipsilateral CAS. METHODS: We studied all patients in the Vascular Quality Initiative (VQI) database, who underwent CEA or CAS between January 1, 2003, and April 30, 2016, after prior ipsilateral CAS. Univariate methods (χ2, t-test), Kaplan-Meier, logistic, and Cox regression analyses adjusting for patient characteristics were employed to evaluate stroke, death, myocardial infarction (MI), stroke/death, and stroke/death/MI within 30 days and up to 1 year following the procedure. RESULTS: There were 645 carotid interventions (CEA, 134 [21%] and redo-CAS, 511 [79%]) performed in this cohort of patients with prior ipsilateral CAS. Postoperative stroke within 30 days comparing CEA vs CAS was 0% vs 0.3% (P = .61) for asymptomatic patients and 4.4% vs 3.5% (P = .79) for symptomatic patients for an overall stroke rate of 1.5% vs 1.4%. MI was 2.3% vs 1.2% (P = .35), 30-day mortality was 3.7% vs 0.9% (P = .02) following CEA vs CAS, whereas the composite of perioperative stroke/death was 4.5% vs 1.9% (P = .09). Freedom from stroke/death at 1 year was 91% for CEA and 92% for redo-CAS (P = .76). After risk adjustment, there was no significant difference in 30-day stroke (odds ratio [OR], 0.82; 95% confidence interval [CI], 0.15-4.48; P = .82), mortality (OR, 2.21; 95% CI, 0.54-9.11; P = .27), or stroke/death (OR, 0.99; 95% CI, 0.26-3.84; P = .99) as well as 1-year stroke (hazard ratio [HR], 0.60; 95% CI, 0.13-2.85; P = .52), mortality (HR, 0.83; 95% CI, 0.42-1.65; P = .60), or stroke/death (HR, 0.80; 95% CI, 0.43-1.49; P = .48) comparing CEA with CAS. The significant predictors of perioperative stroke/death were older age, diabetes, active smoking, and preoperative American Society of Anesthesiologists class IV status (all P < .05). CONCLUSIONS: We have reported adverse event rates for CEA and CAS after prior CAS and shown no significant difference in perioperative and 1-year outcomes between both groups. However, CEA is offered to patients who are more severely ill than redo-CAS, resulting in significantly higher absolute mortality. We recommend avoidance of CEA especially in asymptomatic patients with serious systemic disease. Tight management of diabetes and smoking cessation remain potent targets for outcomes improvement in redo-CAS patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Arhuidese IJ, Nejim B, Chavali S, et al. Endarterectomy versus stenting in patients with prior ipsilateral carotid artery stenting. J Vasc Surg. 2017. PMID: 28190720. doi:10.1016/j.jvs.2016.11.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。